Use access key #2 to skip to page content.
$37.32 1.21 (3.35%)
11/21/2008 4:02 PM

Medco Health Solutions, Inc. (MHS)

CAPS Rating:
*****

Provides sophisticated traditional and specialty prescription drug benefit programs and services for clients, members of client-funded benefit plans and individual patients.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating MHS

Add Stock to Watchlist

What the Community Thinks

Total Members

745 Outperforms
21 Underperforms
 

All-Stars

157 Outperforms
11 Underperforms
 

Wall Street

17 Outperforms
0 Underperforms
 

Members bullish on MHS are also bullish on:

Members bearish on MHS are also bearish on:

Ticker Tags

S&P 500 (469), Large Cap (279), Spin-off - 2006 (21), Health Care Plans (2), Healthcare Providers and Services (129)
Suggest a tag

Medco Health Solutions, Inc. At A Glance

Current Price: $37.32
Last Trade Time: 11/21/2008 4:02 PM
Open: $36.77
Previous Close: $36.11
Daily Range: $34.26 - $37.51
52-Week Range: $29.80 - $54.63
Volume: 7,229,329
Market Cap: $17.98B
P/E Ratio: 17.97
Compare Our Special Broker Offers!

Stock Trends

MHS VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for MHS

More Headlines...

Top Bull Pitch

Recs

1

Medco Health Solutions, Inc. (MHS)

Avatar mrsudbury (23.36) Submitted: 6/14/08 8:19 PM

seems like it's the leader in its industry. also picked express scripts. p/e is high so this is not likely a good caps pick but i use the service as a watchlist. so don't follow my lead. i don't care about my score....

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Medco Health Solutions, Inc. (MHS)

Avatar sarjes (82.90) Submitted: 10/13/06 10:54 PM

I'm not sure about the future of this spinoff from Merck. It provides medication via many prescription drug benefit plans.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 100 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (MHS)

Avatar WilliamCrook2007 (22.91) Submitted: 11/20/08 2:54 PM : Outperform Start Price: $38.06 MHS Score: 2.29

ibd

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MHS)

Avatar ETFinnovators (88.44) Submitted: 11/19/08 8:18 PM : Outperform Start Price: $37.71 MHS Score: 4.33

A New Index of Healthcare Cost Containment Companies


The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table includes companies with market caps over $250M which are involved in the following two segments of the healthcare sector with the common theme of reducing healthcare costs and insurance premiums for consumers, employers, and third-party payers such as the government (through Medicare recipients) and insurance companies.

Generic Healthcare Products: This category includes generic prescription and over-the-counter drug products, led by Teva Pharma (TEVA) and Perrigo (PRGO), respectively. The category also includes diagnostic products such as blood sugar monitors and related supplies, including companies such as Home Diagnostics (HDIX), although its market cap is currently too small to qualify for active inclusion – however it may be an interesting play as an under-the-radar micro-cap value stock.

Pharmacy Benefit Management [PBMs]: This category includes the sale of prescription drugs and diagnostic products by either mail order or network retail pharmacies, specialty pharmacy services and drug product sales, drug plan design & management, drug formulary management, but excludes all activities related to the operation of chain drugstores such as CVS Caremark (CVS) and health insurance plans such as UnitedHealth Group (UNH) in favor of companies such as Express Scripts (ESRX) and MedcoHealth Solutions (MHS).

Health benefit providers are ailing over the past year, with many companies losing over half of their value such as UNH, Aetna (AET), and Humana (HUM) – although the outlook is better for companies which are focused on PBM activities without significant exposure to insurance or retail operations. As I wrote previously, the CEO of MedcoHealth Solutions, Dave Snow, expressed a bullish outlook for next year on their conference call in early November on the prospects for legislation next year to clear the way for high margin generic equivalents to biotech drugs and the possibility for increased healthcare coverage under President-Elect Obama, with the latter expected to increase overall prescription drug sales as more people are covered by drug plans.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MHS)

Avatar EBStroke (73.24) Submitted: 11/05/08 3:17 PM : Outperform Start Price: $41.34 MHS Score: 11.63

Provides sophisticated traditional and specialty prescription drug benefit programs and services for clients, members of client-funded benefit plans and individual patients.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MHS)

Avatar RXDOC73 (94.69) Submitted: 10/28/08 3:33 PM : Outperform Start Price: $45.64 MHS Score: 23.73

The population is just getting older and more people are going to need more drugs. There is a great deal of consolidation in the field and only the strong companies like this one will survive the fallout.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MHS)

Avatar betan1 (91.45) Submitted: 10/24/08 9:22 PM : Outperform Start Price: $34.17 MHS Score: 21.54

This company is in great position to profit from the aging baby boomers, looking for a more convenient way to have access to their prescriptions. Long term Hold here.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 100 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 17 of 17  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer 85.65 09/12/08 Outperform 3W $50.60-26.25%-39.86%+13.61
TrackLeerinkSwan 92.44 06/30/08 Outperform NS $46.71-20.10%-40.72%+20.62
TrackOppenheimer < 20 04/23/08 Outperform NS $50.76-26.48%-44.95%+18.47
TrackJefferies < 20 04/22/08 Outperform NS $51.01-26.84%-45.12%+18.29
TrackCitigroup < 20 04/22/08 Outperform NS $51.01-26.84%-45.12%+18.29
TrackCreditSuiss < 20 04/11/08 Outperform NS $45.34-17.69%-43.76%+26.08
TrackJMP < 20 01/08/08 Outperform NS $52.82-29.34%-46.65%+17.30
TrackHeebner < 20 12/31/07 Outperform NS $50.70-26.39%-48.13%+21.74 Toggle the visibility of 60-Second Pitch and replies
TrackBMOCapital 86.58 11/30/07 Outperform NS $51.65-27.74%-49.12%+21.37
TrackBroadpointC < 20 11/05/07 Outperform NS $47.67-21.72%-49.32%+27.60
TrackEveillard 85.91 09/30/07 Outperform NS $45.19-17.42%-50.30%+32.87 Toggle the visibility of 60-Second Pitch and replies
TrackWMBlair 21.13 09/27/07 Outperform NS $44.49-16.11%-50.41%+34.30
TrackCowenandCo 78.45 09/05/07 Outperform NS $42.88-12.97%-48.83%+35.86
TrackLehmanBros < 20 06/07/07 Outperform NS $39.97-6.63%-50.03%+43.40
TrackMatrix 90.83 05/14/07 Outperform NS $37.90-1.52%-49.73%+48.21
TrackBofASec 95.85 03/08/07 Outperform NS $34.60+7.86%-46.04%+53.90
TrackFirstAlbany 27.62 02/22/07 Outperform NS $34.00+9.76%-48.08%+57.84

Results 1 - 17 of 17  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links